cilostazol has been researched along with potassium chloride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashizume, K; Hori, J; Iwata, T; Kakizaki, H; Kita, M; Matsumoto, S; Wada, N; Watanabe, M | 1 |
Dreier, JP; Hirayama, Y; Hiyoshi, K; Inoue, T; Ishihara, H; Kawano, A; Kawano, R; Kiyohira, M; Maruta, Y; Nomura, S; Oka, F; Okazaki, K; Oku, T; Sadahiro, H; Shinoyama, M; Shirao, S; Suehiro, E; Sugimoto, K; Suzuki, M; Yoneda, H | 1 |
1 trial(s) available for cilostazol and potassium chloride
Article | Year |
---|---|
Cilostazol decreases duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Aged; Animals; Brain Ischemia; Cerebrovascular Circulation; Cilostazol; Cortical Spreading Depression; Disease Models, Animal; Female; Follow-Up Studies; Humans; Intracranial Aneurysm; Male; Middle Aged; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Potassium Chloride; Rats; Rats, Sprague-Dawley; Retrospective Studies; Subarachnoid Hemorrhage | 2018 |
1 other study(ies) available for cilostazol and potassium chloride
Article | Year |
---|---|
Effects of chronic treatment with cilostazol, a phosphodiesterase 3 inhibitor, on female rat bladder in a partial bladder outlet obstruction model.
Topics: Animals; Carbachol; Cilostazol; Disease Models, Animal; Electric Stimulation; Female; Muscle Contraction; Organ Size; Phosphodiesterase 3 Inhibitors; Potassium Chloride; Rats; Rats, Sprague-Dawley; Tetrazoles; Urinary Bladder; Urinary Bladder Neck Obstruction | 2014 |